By combining empathy with clear explanations, clinicians can improve both satisfaction and treatment success
Shantanu Gaur commented: Real-world use of GLP-1s has highlighted three critical issues: poor medication adherence and wrap-around support, muscle and bone mass loss, and untenable cost to the healthcare system.7 ADDRESSING MENTAL HEALTH IMPACT An emerging focus in the field is understanding and managing the psychological aspects of GLP-1 therapy
Perlmutter leads the movement disorders section of the neurology department and is a professor of neuroscience, of occupational therapy, of physical therapy, and of radiology
The CAS Decision reveals that Salazar was prescribed testosterone in 1991 after being diagnosed with testicular failure, later (from 2005) being prescribed with AndroGel
A study in July 2024 by researchers at Mass Eye and Ear in Boston found that people taking semaglutide for type 2 diabetes or weight loss had a higher risk of developing nonarteritic anterior ischemic optic neuropathy, an eye condition that can cause blindness, than people taking medications other than GLP-1 drugs for diabetes or obesity
Common dosing mistakes and how to avoid them After reviewing hundreds of community discussions and researcher reports, certain dosing errors appear repeatedly
